Publicaciones en las que colabora con Beatriz Díaz Molina (18)

2022

  1. Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline Characteristics

    Journal of Clinical Medicine, Vol. 11, Núm. 5

2021

  1. Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 962-970

2020

  1. Pronóstico al año en pacientes con insuficiencia cardiaca en España. Registro ESC-EORP-HFA Heart Failure Long-Term

    REC: CardioClinics, Vol. 55, Núm. 4, pp. 207-216

  2. Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 919-926

2019

  1. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

    European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397

2018

  1. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

    JACC: Heart Failure, Vol. 6, Núm. 6, pp. 452-462

2016

  1. Comentarios a la guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica

    Revista Espanola de Cardiologia, Vol. 69, Núm. 12, pp. 1119-1125

2015

  1. Donor/recipient sex mismatch and survival after heart transplantation: Only an issue in male recipients? An analysis of the Spanish Heart Transplantation Registry

    Transplant International, Vol. 28, Núm. 3, pp. 305-313

  2. First report of the Spanish Post-Heart-Transplant Tumor Registry

    Revista Espanola de Cardiologia Suplementos, Vol. 15, Núm. S2, pp. 50-57

  3. Impact of clinical profile of donor, recipient, and ischemia time on survival of heart transplant patients. Subanalysis of the Spanish Heart Transplantation Registry

    Cirugia Cardiovascular, Vol. 22, Núm. 6, pp. 279-286

2014

  1. The falling incidence of hematologic cancer after heart transplantation

    Clinical Transplantation, Vol. 28, Núm. 10, pp. 1142-1147

2013

  1. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 15, Núm. 10, pp. 1173-1184

2012

  1. Comments on the ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. A report of the task force of the clinical practice guidelines committee of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 65, Núm. 10, pp. 874-878

2011

  1. Lung cancer after heart transplantation: Results from a large multicenter registry

    American Journal of Transplantation, Vol. 11, Núm. 5, pp. 1035-1040

2010

  1. The prognosis of noncutaneous, nonlymphomatous malignancy after heart transplantation: Data from the Spanish post-heart transplant tumour registry

    Transplantation Proceedings, Vol. 42, Núm. 8, pp. 3011-3013

2008

  1. Malignancy after heart transplantation: Incidence, prognosis and risk factors

    American Journal of Transplantation, Vol. 8, Núm. 5, pp. 1031-1039

2007

  1. The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection

    American Journal of Transplantation, Vol. 7, Núm. 7, pp. 1842-1848

2006

  1. The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection

    Transplantation, Vol. 82, Núm. 3, pp. 354-361